Acarbose and insulin therapy in type I diabetes mellitus
Author:
- 1 August 1994
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 24 (S3) , 36-39
Abstract
In this paper relevant studies are summarized regarding the use of acarbose as an adjunct to insulin in the treatment of type I diabetes. It is concluded that this approach may contribute to a reduction of postprandial blood glucose excursions and a smoothening of daily blood glucose profiles, an improvement of metabolic control as expressed by glycosylate haemoglobin values and a reduction of insulin requirements. Long-term studies are, however, necessary before one can conclude that addition of acarbose to the therapeutic regimen in type I diabetic subjects is of longstanding value.Keywords
This publication has 12 references indexed in Scilit:
- European experience in the treatment of IDDM with acarbose in combination with insulin1992
- Two multi-center, double-blind, placebo-controlled studies of efficacy and safety of acarbose treatment of type I diabetes1992
- Effects of acarbose on blood glucose control in insulindependent diabetes mellitus1992
- Prospective, multi-center studies of the efficacy and safety of acarbose (BAY g 5421) in the treatment of type I diabetes mellitus1992
- Effects of α-Glucosidase Inhibition on Meal Glucose Tolerance and Timing of Insulin Administration in Patients With Type I Diabetes MellitusDiabetes Care, 1991
- Nonrandomized Follow-up Study with Acarbose Treatment and Pre- and Post-treatment with Placebo in Type I Diabetic Children1988
- Effects of Prolonged (6 Months) α-Glucosidase Inhibition on Blood Glucose Control and Insulin Requirements in Patients with Insulin-Dependent Diabetes MellitusHormone and Metabolic Research, 1986
- Effect of the?? glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabeticsDiabetologia, 1979
- Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.BMJ, 1979
- The M‐Value, an Index of Blood‐sugar Control in DiabeticsActa Medica Scandinavica, 1965